| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | RNA-DNA hybrid ribonuclease activity | 5.26e-08 | 11 | 209 | 5 | GO:0004523 | |
| GeneOntologyMolecularFunction | aspartic-type endopeptidase activity | 9.82e-08 | 37 | 209 | 7 | GO:0004190 | |
| GeneOntologyMolecularFunction | aspartic-type peptidase activity | 1.19e-07 | 38 | 209 | 7 | GO:0070001 | |
| GeneOntologyMolecularFunction | RNA-directed DNA polymerase activity | 2.22e-07 | 14 | 209 | 5 | GO:0003964 | |
| GeneOntologyMolecularFunction | RNA stem-loop binding | 2.13e-06 | 21 | 209 | 5 | GO:0035613 | |
| GeneOntologyMolecularFunction | RNA endonuclease activity, producing 5'-phosphomonoesters | 3.97e-05 | 37 | 209 | 5 | GO:0016891 | |
| GeneOntologyMolecularFunction | DNA polymerase activity | 4.54e-05 | 38 | 209 | 5 | GO:0034061 | |
| GeneOntologyMolecularFunction | galactoside binding | 9.06e-05 | 9 | 209 | 3 | GO:0016936 | |
| GeneOntologyMolecularFunction | endonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 5'-phosphomonoesters | 1.16e-04 | 46 | 209 | 5 | GO:0016893 | |
| GeneOntologyMolecularFunction | semaphorin receptor activity | 2.32e-04 | 12 | 209 | 3 | GO:0017154 | |
| GeneOntologyMolecularFunction | structural molecule activity | ERVK-6 EPPK1 ERVK-7 ERVK-10 NPHP4 HMCN2 ERVK-18 COL14A1 ERVK-19 ERVK-25 HSPG2 FRAS1 MXRA5 COL12A1 SYNM PPFIA2 KRT23 HMCN1 ERVK-8 LTBP1 EPB42 | 4.53e-04 | 891 | 209 | 21 | GO:0005198 |
| GeneOntologyMolecularFunction | peptidase activity | ERVK-6 ERVK-7 ERVK-10 ERVK-18 ERVK-19 ERVK-25 TRHDE CPA6 PRSS57 PITRM1 HTRA3 CPD KY OTUD7A ERVK-8 EIF3F USP54 | 5.46e-04 | 654 | 209 | 17 | GO:0008233 |
| GeneOntologyMolecularFunction | endonuclease activity | 5.81e-04 | 136 | 209 | 7 | GO:0004519 | |
| GeneOntologyMolecularFunction | acetyl-CoA binding | 6.45e-04 | 4 | 209 | 2 | GO:1905502 | |
| GeneOntologyMolecularFunction | extracellular matrix structural constituent | 8.41e-04 | 188 | 209 | 8 | GO:0005201 | |
| GeneOntologyMolecularFunction | calcium ion binding | PRRG1 STIM1 ESYT2 FAT2 HMCN2 PCDH11X PLCB1 ASTN2 HSPG2 SGCA PCDHB8 HMCN1 LRP1 RASEF LTBP1 CDH10 CDH15 MAN1B1 | 9.33e-04 | 749 | 209 | 18 | GO:0005509 |
| GeneOntologyMolecularFunction | zinc ion binding | ERVK-6 NR2C2 HIVEP1 MYCBP2 ERVK-7 ERVK-10 GATAD2B TRAFD1 ERVK-19 HERC2 ERVK-11 TRHDE CPA6 PITRM1 NR4A2 CPD ZNF3 TRIM9 OTUD7A ERVK-8 | 1.13e-03 | 891 | 209 | 20 | GO:0008270 |
| GeneOntologyMolecularFunction | RNA endonuclease activity | 1.44e-03 | 79 | 209 | 5 | GO:0004521 | |
| GeneOntologyBiologicalProcess | DNA integration | 1.68e-09 | 13 | 210 | 6 | GO:0015074 | |
| GeneOntologyBiologicalProcess | homophilic cell adhesion via plasma membrane adhesion molecules | PRTG FAT2 HMCN2 PCDH11X SDK1 PLXNB3 SDK2 PCDHB8 HMCN1 IGSF21 CDH10 CDH15 | 5.07e-07 | 187 | 210 | 12 | GO:0007156 |
| GeneOntologyBiologicalProcess | cell-cell adhesion via plasma-membrane adhesion molecules | LGALS9C PRTG LGALS9B FAT2 HMCN2 PCDH11X SDK1 PLXNB3 SDK2 PCDHB8 HMCN1 IGSF21 CDH10 CDH15 | 4.27e-06 | 313 | 210 | 14 | GO:0098742 |
| GeneOntologyBiologicalProcess | cell morphogenesis | EPHB6 PRTG RAPH1 MYCBP2 RNF157 KIAA0319 MYO3A HMCN2 PLPPR4 PLXNB1 PLXNB3 TBCD PLXNA3 HSPG2 DDR1 PPFIA2 CNTNAP1 NR4A2 MED1 JMJD1C TRAK1 TSKU FAM171A1 LIFR EGR2 LRP1 AUTS2 CDH10 CDH15 EPB42 | 4.37e-06 | 1194 | 210 | 30 | GO:0000902 |
| GeneOntologyBiologicalProcess | DNA synthesis involved in DNA repair | 8.91e-06 | 48 | 210 | 6 | GO:0000731 | |
| GeneOntologyBiologicalProcess | axonogenesis | EPHB6 PRTG RAPH1 MYCBP2 KIAA0319 HMCN2 PLPPR4 PLXNB1 PLXNB3 PLXNA3 HSPG2 CNTNAP1 NR4A2 TRAK1 TSKU EGR2 LRP1 AUTS2 | 2.11e-05 | 566 | 210 | 18 | GO:0007409 |
| GeneOntologyBiologicalProcess | neuron projection morphogenesis | EPHB6 PRTG RAPH1 MYCBP2 RNF157 KIAA0319 HMCN2 PLPPR4 PLXNB1 PLXNB3 PLXNA3 HSPG2 DDR1 PPFIA2 CNTNAP1 NR4A2 TRAK1 TSKU LIFR EGR2 LRP1 AUTS2 | 2.49e-05 | 802 | 210 | 22 | GO:0048812 |
| GeneOntologyBiologicalProcess | cell morphogenesis involved in neuron differentiation | EPHB6 PRTG RAPH1 MYCBP2 KIAA0319 MYO3A HMCN2 PLPPR4 PLXNB1 PLXNB3 TBCD PLXNA3 HSPG2 PPFIA2 CNTNAP1 NR4A2 TRAK1 TSKU EGR2 LRP1 AUTS2 | 2.75e-05 | 748 | 210 | 21 | GO:0048667 |
| GeneOntologyBiologicalProcess | axon development | EPHB6 PRTG RAPH1 MYCBP2 KIAA0319 HMCN2 PLPPR4 PLXNB1 PLXNB3 PLXNA3 HSPG2 DDR1 CNTNAP1 NR4A2 TRAK1 TSKU EGR2 LRP1 AUTS2 | 3.32e-05 | 642 | 210 | 19 | GO:0061564 |
| GeneOntologyBiologicalProcess | plasma membrane bounded cell projection morphogenesis | EPHB6 PRTG RAPH1 MYCBP2 RNF157 KIAA0319 HMCN2 PLPPR4 PLXNB1 PLXNB3 PLXNA3 HSPG2 DDR1 PPFIA2 CNTNAP1 NR4A2 TRAK1 TSKU LIFR EGR2 LRP1 AUTS2 | 3.42e-05 | 819 | 210 | 22 | GO:0120039 |
| GeneOntologyBiologicalProcess | cell projection morphogenesis | EPHB6 PRTG RAPH1 MYCBP2 RNF157 KIAA0319 HMCN2 PLPPR4 PLXNB1 PLXNB3 PLXNA3 HSPG2 DDR1 PPFIA2 CNTNAP1 NR4A2 TRAK1 TSKU LIFR EGR2 LRP1 AUTS2 | 3.89e-05 | 826 | 210 | 22 | GO:0048858 |
| GeneOntologyBiologicalProcess | cell junction organization | MYCBP2 ASIC2 HIPK1 CHAT NPHP4 ASAP1 LRFN2 HMCN2 PLPPR4 ADGRF1 SDK1 PLXNB1 TBCD SDK2 PPFIA2 CNTNAP1 PCDHB8 KY PPM1F LRP1 KIRREL1 IGSF21 CDH10 CDH15 | 5.86e-05 | 974 | 210 | 24 | GO:0034330 |
| GeneOntologyBiologicalProcess | cell-cell adhesion | EPHB6 LGALS9C PRTG LGALS9B RIPK2 NPHP4 TYRO3 FAT2 HMCN2 PCDH11X ASTN2 COL14A1 SDK1 PLXNB3 SDK2 PCDHB8 AMBRA1 HMCN1 PPM1F KIRREL1 SIGLEC1 IGSF21 CDH10 CDH15 CD276 | 1.05e-04 | 1077 | 210 | 25 | GO:0098609 |
| GeneOntologyBiologicalProcess | DNA recombination | ERVK-6 EPC2 ERVK-7 ERVK-10 HROB EME2 ERVK-11 RAD51B PMS2 SMCHD1 PAXIP1 ERVK-8 SLX4 | 1.08e-04 | 368 | 210 | 13 | GO:0006310 |
| GeneOntologyBiologicalProcess | RNA-templated DNA biosynthetic process | 2.04e-04 | 83 | 210 | 6 | GO:0006278 | |
| GeneOntologyBiologicalProcess | branching involved in mammary gland duct morphogenesis | 2.33e-04 | 30 | 210 | 4 | GO:0060444 | |
| GeneOntologyCellularComponent | histone deacetylase complex | 2.16e-04 | 85 | 210 | 6 | GO:0000118 | |
| GeneOntologyCellularComponent | semaphorin receptor complex | 2.65e-04 | 13 | 210 | 3 | GO:0002116 | |
| GeneOntologyCellularComponent | anchoring collagen complex | 2.99e-04 | 3 | 210 | 2 | GO:0030934 | |
| Domain | Ig-like_fold | EPHB6 PRTG MYCBP2 KIAA0319 GHR TYRO3 LRFN2 IL22RA2 PTPRB HMCN2 ALPK3 ASTN2 COL14A1 SDK1 PLXNB1 PLXNB3 PLXNA3 HSPG2 SDK2 MXRA5 COL12A1 SGCA LIFR HMCN1 TRIM9 KIRREL1 TGM7 SIGLEC1 IGSF21 EPB42 CD276 | 2.56e-11 | 706 | 201 | 31 | IPR013783 |
| Domain | - | EPHB6 PRTG MYCBP2 GHR TYRO3 LRFN2 IL22RA2 PTPRB ALPK3 ASTN2 COL14A1 SDK1 PLXNB1 PLXNB3 PLXNA3 HSPG2 SDK2 MXRA5 COL12A1 SGCA LIFR HMCN1 TRIM9 KIRREL1 TGM7 SIGLEC1 IGSF21 EPB42 CD276 | 1.32e-10 | 663 | 201 | 29 | 2.60.40.10 |
| Domain | FN3_dom | EPHB6 PRTG KIAA0319 GHR TYRO3 LRFN2 IL22RA2 PTPRB ASTN2 COL14A1 SDK1 SDK2 COL12A1 LIFR TRIM9 | 8.29e-09 | 209 | 201 | 15 | IPR003961 |
| Domain | FN3 | EPHB6 PRTG KIAA0319 GHR TYRO3 LRFN2 PTPRB ASTN2 COL14A1 SDK1 SDK2 COL12A1 LIFR TRIM9 | 1.35e-08 | 185 | 201 | 14 | SM00060 |
| Domain | FN3 | EPHB6 PRTG GHR TYRO3 LRFN2 IL22RA2 PTPRB ASTN2 COL14A1 SDK1 SDK2 COL12A1 LIFR TRIM9 | 3.41e-08 | 199 | 201 | 14 | PS50853 |
| Domain | fn3 | EPHB6 PRTG GHR TYRO3 LRFN2 PTPRB COL14A1 SDK1 SDK2 COL12A1 LIFR TRIM9 | 1.91e-07 | 162 | 201 | 12 | PF00041 |
| Domain | Ig_I-set | PRTG TYRO3 LRFN2 HMCN2 ALPK3 SDK1 HSPG2 SDK2 MXRA5 HMCN1 KIRREL1 SIGLEC1 | 1.06e-06 | 190 | 201 | 12 | IPR013098 |
| Domain | I-set | PRTG TYRO3 LRFN2 HMCN2 ALPK3 SDK1 HSPG2 SDK2 MXRA5 HMCN1 KIRREL1 SIGLEC1 | 1.06e-06 | 190 | 201 | 12 | PF07679 |
| Domain | IGc2 | PRTG TYRO3 LRFN2 HMCN2 ALPK3 SDK1 HSPG2 SDK2 MXRA5 HMCN1 KIRREL1 SIGLEC1 CD276 | 1.66e-06 | 235 | 201 | 13 | SM00408 |
| Domain | Ig_sub2 | PRTG TYRO3 LRFN2 HMCN2 ALPK3 SDK1 HSPG2 SDK2 MXRA5 HMCN1 KIRREL1 SIGLEC1 CD276 | 1.66e-06 | 235 | 201 | 13 | IPR003598 |
| Domain | - | 7.48e-05 | 95 | 201 | 7 | 2.60.120.200 | |
| Domain | Plexin_cytopl | 9.83e-05 | 9 | 201 | 3 | PF08337 | |
| Domain | Plexin_cytoplasmic_RasGAP_dom | 9.83e-05 | 9 | 201 | 3 | IPR013548 | |
| Domain | Plexin | 9.83e-05 | 9 | 201 | 3 | IPR031148 | |
| Domain | Ig_E-set | 1.33e-04 | 104 | 201 | 7 | IPR014756 | |
| Domain | - | 1.35e-04 | 73 | 201 | 6 | 2.60.120.260 | |
| Domain | Transglutaminase-like | 1.90e-04 | 11 | 201 | 3 | IPR002931 | |
| Domain | TGc | 1.90e-04 | 11 | 201 | 3 | SM00460 | |
| Domain | Transglut_core | 1.90e-04 | 11 | 201 | 3 | PF01841 | |
| Domain | IG | PRTG TYRO3 LRFN2 HMCN2 ALPK3 SDK1 HSPG2 SDK2 MXRA5 HMCN1 KIRREL1 SIGLEC1 IGSF21 CD276 | 1.96e-04 | 421 | 201 | 14 | SM00409 |
| Domain | Ig_sub | PRTG TYRO3 LRFN2 HMCN2 ALPK3 SDK1 HSPG2 SDK2 MXRA5 HMCN1 KIRREL1 SIGLEC1 IGSF21 CD276 | 1.96e-04 | 421 | 201 | 14 | IPR003599 |
| Domain | Cadherin | 2.90e-04 | 118 | 201 | 7 | IPR002126 | |
| Domain | Growth_fac_rcpt_ | 2.92e-04 | 156 | 201 | 8 | IPR009030 | |
| Domain | Laminin_G | 3.96e-04 | 58 | 201 | 5 | IPR001791 | |
| Domain | Galactose-bd-like | 5.35e-04 | 94 | 201 | 6 | IPR008979 | |
| Domain | ConA-like_dom | LGALS9C LGALS9B NBEAL1 FAT2 COL14A1 HSPG2 COL12A1 CNTNAP1 TRIM9 | 6.28e-04 | 219 | 201 | 9 | IPR013320 |
| Domain | G2F | 6.82e-04 | 4 | 201 | 2 | PF07474 | |
| Domain | NIDOGEN_G2 | 6.82e-04 | 4 | 201 | 2 | PS50993 | |
| Domain | GFP | 6.82e-04 | 4 | 201 | 2 | IPR009017 | |
| Domain | G2_nidogen/fibulin_G2F | 6.82e-04 | 4 | 201 | 2 | IPR006605 | |
| Domain | IG_LIKE | PRTG TYRO3 LRFN2 HMCN2 ALPK3 SDK1 HSPG2 SDK2 MXRA5 HMCN1 KIRREL1 SIGLEC1 IGSF21 CD276 | 9.02e-04 | 491 | 201 | 14 | PS50835 |
| Domain | INTEGRASE | 1.13e-03 | 5 | 201 | 2 | PS50994 | |
| Domain | Integrase_cat-core | 1.13e-03 | 5 | 201 | 2 | IPR001584 | |
| Domain | Ig-like_dom | PRTG TYRO3 LRFN2 HMCN2 ALPK3 SDK1 HSPG2 SDK2 MXRA5 HMCN1 KIRREL1 SIGLEC1 IGSF21 CD276 | 1.14e-03 | 503 | 201 | 14 | IPR007110 |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | CPAMD8 HIVEP2 ACACA MYCBP2 BTBD9 RBBP8NL CASC2 ESYT2 LRFN2 PTPRB KCND3 ASTN2 TNFRSF19 ARHGEF37 SAP130 MAML3 TBCD NPAS2 RAD51B DDR1 SCAF8 WWP1 PPFIA2 RNF213 CPD JMJD1C EEF1A2 ANKRD44 PACS1 ZNF827 KIAA1217 LRP1 AUTS2 RASEF CSMD1 MBD5 PRDM15 CDH15 MAN1B1 | 1.48e-14 | 1489 | 213 | 39 | 28611215 |
| Pubmed | NR2C2 HIVEP1 ACACA RAPH1 MYCBP2 RBBP8NL BIRC6 PHF21A TAF1 ARHGAP21 CSTPP1 NPAT HDAC5 GEMIN5 RFX1 JMJD1C DENND4C PPM1F ZNF516 LRP1 | 1.83e-12 | 418 | 213 | 20 | 34709266 | |
| Pubmed | EPC2 NR2C2 HIVEP1 TBL1Y GATAD2B PHF21A SYNE2 TAF1 HERC2 DNAJA1 SAP130 NPAT HSPG2 EDC3 HDAC5 PITRM1 SCAF8 SMCHD1 RFX7 RFX1 ZNF768 JMJD1C ZNF3 TRIM9 PES1 ZNF516 PAXIP1 AUTS2 ELF1 EIF3F USP54 SLX4 | 2.48e-10 | 1429 | 213 | 32 | 35140242 | |
| Pubmed | Identification and functional characterization of transcriptional activators in human cells. | EPC2 NR2C2 HIVEP1 GATAD2B PHF21A GLA SYNE2 TAF1 DNAJA1 RBL1 GEMIN5 JMJD1C ZNF516 PAXIP1 AUTS2 USP54 ZNF292 | 5.11e-10 | 398 | 213 | 17 | 35016035 |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | HIVEP1 HIVEP2 ACACA RAPH1 MYCBP2 RIPK2 STIM1 ESYT2 SYNE2 ARHGAP21 EDC3 RAB11FIP1 RFX7 DENND4C TRAK1 EEF1A2 FAM171A1 SLC12A2 TRIM9 KIAA1217 OTUD7A USP54 CDC25B | 4.06e-09 | 861 | 213 | 23 | 36931259 |
| Pubmed | EPC2 PEX6 GATAD2B PHF21A TRAFD1 HMCN2 SETSIP TAF1 DNAJA1 SAP130 SET RBL1 WWP1 AOX1 KIAA1549 RNF213 AMBRA1 RAB11FIP1 ZNF768 INTS10 ZNF827 LRP1 SIGLEC1 USP54 CSMD1 CDH15 | 6.27e-09 | 1116 | 213 | 26 | 31753913 | |
| Pubmed | Quantitation of HERV-K env gene expression and splicing in human breast cancer. | 6.81e-09 | 5 | 213 | 4 | 12629516 | |
| Pubmed | RAPH1 MYCBP2 BIRC6 ASAP1 STIM1 ESYT2 PTPRB SYNE2 HERC2 DNAJA1 PMS2 PPM1D KIAA1549 RNF213 CPD RAB11FIP1 FAM171A1 PACS1 SLC12A2 PPM1F PES1 KIRREL1 LTBP1 CDC25B | 3.53e-08 | 1049 | 213 | 24 | 27880917 | |
| Pubmed | A dual-strategy expression screen for candidate connectivity labels in the developing thalamus. | 9.54e-08 | 91 | 213 | 8 | 28558017 | |
| Pubmed | A revised nomenclature for transcribed human endogenous retroviral loci. | ERVK-6 ERVK-7 ERVK-10 ERVK-18 ERVK-19 ERVK-25 ERVK-11 ERVK-8 | 1.23e-07 | 94 | 213 | 8 | 21542922 |
| Pubmed | HIVEP1 MYCBP2 HIPK1 PEX6 GATAD2B HERC2 SAP130 SDK1 TBCD HSPG2 WWP1 RFX1 TRAK1 TSKU PAXIP1 LRP1 EIF3F | 1.69e-07 | 591 | 213 | 17 | 15231748 | |
| Pubmed | 2.27e-07 | 3 | 213 | 3 | 10516026 | ||
| Pubmed | Interaction network of human early embryonic transcription factors. | EPC2 NR2C2 HIVEP1 HIVEP2 PHF21A TAF1 HDAC5 RFX7 EGR2 ZNF516 PAXIP1 AUTS2 SLX4 | 3.03e-07 | 351 | 213 | 13 | 38297188 |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | HIVEP1 ACACA RAPH1 MYCBP2 GATAD2B ESYT2 MYO3A TRAFD1 OSBPL11 SCAF8 GEMIN5 MED1 RFX7 RFX1 ZNF768 PACS1 ZNF516 TRAPPC10 ELF1 | 3.55e-07 | 774 | 213 | 19 | 15302935 |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | EPPK1 HIVEP2 ACACA MYCBP2 PEX6 NPHP4 BIRC6 AP1G2 HERC2 ARHGAP21 TBCD PLXNA3 HSPG2 FRAS1 WWP1 GEMIN5 AMBRA1 TRAK1 ZNF827 ZNF516 PAXIP1 MBD5 CD276 | 3.67e-07 | 1105 | 213 | 23 | 35748872 |
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | NR2C2 MYCBP2 STIM1 GLA ARHGAP21 PLXNB1 PLXNA3 HSPG2 FRAS1 COL12A1 EDC3 CNTNAP1 KIAA1549 RNF213 CPD TSKU LIFR SLC12A2 PES1 LRP1 KIRREL1 LTBP1 MAN1B1 CD276 | 4.17e-07 | 1201 | 213 | 24 | 35696571 |
| Pubmed | ARHGAP21 CSTPP1 SYNM KIAA1549 CPD JMJD1C SLC12A2 TRIM9 KIAA1217 KIRREL1 USP54 | 7.71e-07 | 263 | 213 | 11 | 34702444 | |
| Pubmed | 7.92e-07 | 52 | 213 | 6 | 26633812 | ||
| Pubmed | Galectin-9 inhibits TLR7-mediated autoimmunity in murine lupus models. | 9.02e-07 | 4 | 213 | 3 | 29611821 | |
| Pubmed | Many human endogenous retrovirus K (HERV-K) proviruses are unique to humans. | 9.02e-07 | 4 | 213 | 3 | 10469592 | |
| Pubmed | 9.02e-07 | 4 | 213 | 3 | 7983737 | ||
| Pubmed | EPHB6 HIVEP2 MYCBP2 CNST HIPK1 ASTN2 TAF1 HERC2 DNAJA1 TARBP1 ARHGAP21 PLXNB3 ABHD14A PMS2 SYNM CNTNAP1 NR4A2 EEF1A2 TRIM9 LRP1 EIF3F USP54 SLX4 ZNF292 | 1.37e-06 | 1285 | 213 | 24 | 35914814 | |
| Pubmed | MYCBP2 TBL1Y RIPK2 BTBD9 GATAD2B KIAA0319 PLPPR4 SYNE2 PLCB1 HERC2 DNAJA1 ARHGAP21 HCN3 CNTNAP1 EEF1A2 FAM171A1 KIAA1217 ZNF516 LRP1 CDH10 | 2.29e-06 | 963 | 213 | 20 | 28671696 | |
| Pubmed | ACACA STIM1 ESYT2 PLCB1 ARHGAP21 CSTPP1 CPD RAB11FIP1 FAM171A1 PACS1 SLC12A2 KIAA1217 KIRREL1 | 2.30e-06 | 421 | 213 | 13 | 36976175 | |
| Pubmed | BCL2L2 BTBD9 NPHP4 BIRC6 GATAD2B FAT2 ASTN2 MAML3 SYNM RNF213 JMJD1C MBD5 SLX4 UTP14C | 2.48e-06 | 493 | 213 | 14 | 15368895 | |
| Pubmed | HIVEP1 MYCBP2 BIRC6 ASAP1 SYNE2 COL14A1 TAF1 ARHGAP21 HSPG2 SET COL12A1 SGCA WWP1 JMJD1C | 2.72e-06 | 497 | 213 | 14 | 23414517 | |
| Pubmed | 3.53e-06 | 103 | 213 | 7 | 10574462 | ||
| Pubmed | 3.91e-06 | 18 | 213 | 4 | 18664271 | ||
| Pubmed | 4.47e-06 | 6 | 213 | 3 | 30687002 | ||
| Pubmed | EPC2 NBEAL1 BCL2L2 STIM1 ESYT2 TARBP1 TBCD PMS2 COL12A1 EDC3 HCN3 NR4A2 ZNF516 MBD5 PRDM15 MAN1B1 | 6.20e-06 | 689 | 213 | 16 | 36543142 | |
| Pubmed | 8.21e-06 | 117 | 213 | 7 | 17145500 | ||
| Pubmed | A Global Analysis of the Receptor Tyrosine Kinase-Protein Phosphatase Interactome. | EPHB6 NPHP4 TYRO3 TRAFD1 PTPRB HERC2 TRHDE PPM1F KIAA1217 ZNF516 LRP1 CDC25B | 1.24e-05 | 420 | 213 | 12 | 28065597 |
| Pubmed | 1.24e-05 | 8 | 213 | 3 | 15661641 | ||
| Pubmed | The functional interactome landscape of the human histone deacetylase family. | MYCBP2 GATAD2B PHF21A SYNE2 DNAJA1 SAP130 HDAC5 ZNF827 PES1 ZNF516 | 1.31e-05 | 289 | 213 | 10 | 23752268 |
| Pubmed | 1.34e-05 | 175 | 213 | 8 | 28071719 | ||
| Pubmed | Circular rapid amplification of cDNA ends for high-throughput extension cloning of partial genes. | 1.34e-05 | 84 | 213 | 6 | 15203218 | |
| Pubmed | 1.46e-05 | 177 | 213 | 8 | 26206133 | ||
| Pubmed | Substrate trapping proteomics reveals targets of the βTrCP2/FBXW11 ubiquitin ligase. | 1.48e-05 | 128 | 213 | 7 | 25332235 | |
| Pubmed | Targeting TRIM37-driven centrosome dysfunction in 17q23-amplified breast cancer. | 1.93e-05 | 184 | 213 | 8 | 32908313 | |
| Pubmed | Identification of proximal SUMO-dependent interactors using SUMO-ID. | NR2C2 ACACA NAA80 GATAD2B PHF21A MED26 EDC3 SMCHD1 MED1 JMJD1C EIF3F SLX4 | 2.14e-05 | 444 | 213 | 12 | 34795231 |
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | NR2C2 HIVEP1 GATAD2B TAF1 HERC2 NPAT SMCHD1 MED1 RFX1 JMJD1C PES1 ELF1 PRDM15 ZNF292 | 2.62e-05 | 608 | 213 | 14 | 36089195 |
| Pubmed | PHF21A PLPPR4 PLCB1 PLXNB1 SDK2 PITRM1 SMCHD1 KIAA1549 AMBRA1 TRIM9 PPM1F ZNF516 AUTS2 | 2.62e-05 | 529 | 213 | 13 | 14621295 | |
| Pubmed | 3.73e-05 | 2 | 213 | 2 | 15609093 | ||
| Pubmed | Sidekick-1 is upregulated in glomeruli in HIV-associated nephropathy. | 3.73e-05 | 2 | 213 | 2 | 15213259 | |
| Pubmed | Definition of the critical domains required for homophilic targeting of mouse sidekick molecules. | 3.73e-05 | 2 | 213 | 2 | 15703275 | |
| Pubmed | 3.73e-05 | 2 | 213 | 2 | 30150416 | ||
| Pubmed | 3.73e-05 | 2 | 213 | 2 | 17960519 | ||
| Pubmed | 3.73e-05 | 2 | 213 | 2 | 10642512 | ||
| Pubmed | Abnormal corneal endothelial maturation in collagen XII and XIV null mice. | 3.73e-05 | 2 | 213 | 2 | 23599329 | |
| Pubmed | Mammalian hemicentin 1 is assembled into tracks in the extracellular matrix of multiple tissues. | 3.73e-05 | 2 | 213 | 2 | 32035013 | |
| Pubmed | 3.73e-05 | 2 | 213 | 2 | 9060628 | ||
| Pubmed | 3.73e-05 | 2 | 213 | 2 | 36490282 | ||
| Pubmed | Evolutionary relationships within a subgroup of HERV-K-related human endogenous retroviruses. | 3.73e-05 | 2 | 213 | 2 | 9460924 | |
| Pubmed | 3.73e-05 | 2 | 213 | 2 | 32879390 | ||
| Pubmed | Sidekicks: synaptic adhesion molecules that promote lamina-specific connectivity in the retina. | 3.73e-05 | 2 | 213 | 2 | 12230981 | |
| Pubmed | 3.73e-05 | 2 | 213 | 2 | 32781065 | ||
| Pubmed | Interferon-alpha-induced endogenous superantigen. a model linking environment and autoimmunity. | 3.73e-05 | 2 | 213 | 2 | 11672541 | |
| Pubmed | Molecular basis of sidekick-mediated cell-cell adhesion and specificity. | 3.73e-05 | 2 | 213 | 2 | 27644106 | |
| Pubmed | Oct4 links multiple epigenetic pathways to the pluripotency network. | 3.89e-05 | 203 | 213 | 8 | 22083510 | |
| Pubmed | Coeliac disease-associated risk variants in TNFAIP3 and REL implicate altered NF-kappaB signalling. | MYCBP2 IL22RA2 PLCB1 ANKRD44 SLC12A2 ZNF827 AUTS2 CSMD1 IGSF21 | 4.10e-05 | 265 | 213 | 9 | 19240061 |
| Pubmed | 4.48e-05 | 268 | 213 | 9 | 33640491 | ||
| Pubmed | 4.67e-05 | 64 | 213 | 5 | 22261194 | ||
| Pubmed | HIPK1 RNF157 ASAP1 KIAA0319 LRFN2 ARHGAP21 PLXNB3 FRAS1 HDAC5 SCAF8 TRAK1 | 4.72e-05 | 407 | 213 | 11 | 12693553 | |
| Pubmed | Transmembrane semaphorin signalling controls laminar stratification in the mammalian retina. | 4.78e-05 | 12 | 213 | 3 | 21270798 | |
| Pubmed | 4.78e-05 | 12 | 213 | 3 | 14557543 | ||
| Pubmed | Menin and Menin-Associated Proteins Coregulate Cancer Energy Metabolism. | GATAD2B SAP130 PMS2 PPM1D SMCHD1 RNF213 MED1 RFX1 JMJD1C PAXIP1 | 5.32e-05 | 341 | 213 | 10 | 32971831 |
| Pubmed | EPC2 NR2C2 HIVEP1 MYCBP2 BCL2L2 GATAD2B PHF21A SAP130 SET SMCHD1 MED1 RFX1 JMJD1C ZNF3 PES1 ZNF516 PAXIP1 ELF1 ZNF292 | 5.44e-05 | 1103 | 213 | 19 | 34189442 | |
| Pubmed | The Functional Proximal Proteome of Oncogenic Ras Includes mTORC2. | ESYT2 PCDH11X PLCB1 ARHGAP21 PLXNB1 WWP1 KIAA1549 CPD RAB11FIP1 PACS1 SLC12A2 KIRREL1 CD276 | 5.51e-05 | 569 | 213 | 13 | 30639242 |
| Pubmed | DNA Damage Regulates Translation through β-TRCP Targeting of CReP. | 6.17e-05 | 35 | 213 | 4 | 26091241 | |
| Pubmed | 6.19e-05 | 13 | 213 | 3 | 10520995 | ||
| Pubmed | EGR1 and EGR2 involvement in vertebrate tendon differentiation. | 6.19e-05 | 13 | 213 | 3 | 21173153 | |
| Pubmed | 6.69e-05 | 162 | 213 | 7 | 25826454 | ||
| Pubmed | 7.84e-05 | 14 | 213 | 3 | 28511701 | ||
| Pubmed | MKRN2 Physically Interacts with GLE1 to Regulate mRNA Export and Zebrafish Retinal Development. | 7.96e-05 | 358 | 213 | 10 | 32460013 | |
| Pubmed | 8.01e-05 | 225 | 213 | 8 | 12168954 | ||
| Pubmed | 8.10e-05 | 167 | 213 | 7 | 22159717 | ||
| Pubmed | SR protein kinases promote splicing of nonconsensus introns. | HIVEP1 RAPH1 MYCBP2 GHR HMCN2 DNAH9 SDK2 SMCHD1 GEMIN5 JMJD1C | 8.53e-05 | 361 | 213 | 10 | 26167880 |
| Pubmed | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. | EPC2 NR2C2 TBL1Y HIPK1 GATAD2B PHF21A ESYT2 SAP130 HDAC5 RBL1 RFX1 CREM JMJD1C PES1 LRP1 PRDM15 | 8.56e-05 | 857 | 213 | 16 | 25609649 |
| Pubmed | Transcriptome analysis of mouse stem cells and early embryos. | SUPT20HL1 ACACA BIRC6 ASAP1 DNAJA1 HNRNPCL2 HSPG2 COL12A1 SMCHD1 SLC12A2 | 8.92e-05 | 363 | 213 | 10 | 14691545 |
| Pubmed | Detection of differentially expressed genes in the early developmental stage of the mouse mandible. | 9.76e-05 | 15 | 213 | 3 | 11461004 | |
| Pubmed | NPHP4 AP1G2 HERC2 DNAJA1 ARHGAP21 HNRNPCL2 PCDHB8 CREM JMJD1C EGR2 | 1.07e-04 | 371 | 213 | 10 | 15747579 | |
| Pubmed | 1.12e-04 | 3 | 213 | 2 | 12388743 | ||
| Pubmed | 1.12e-04 | 3 | 213 | 2 | 19776007 | ||
| Pubmed | 1.12e-04 | 3 | 213 | 2 | 33316546 | ||
| Pubmed | 1.12e-04 | 3 | 213 | 2 | 9038233 | ||
| Pubmed | 1.12e-04 | 3 | 213 | 2 | 28704475 | ||
| Pubmed | 1.12e-04 | 3 | 213 | 2 | 27384677 | ||
| Pubmed | 1.12e-04 | 3 | 213 | 2 | 23836896 | ||
| Pubmed | Sequence and mapping of galectin-5, a beta-galactoside-binding lectin, found in rat erythrocytes. | 1.12e-04 | 3 | 213 | 2 | 7890611 | |
| Pubmed | Galectin-9 suppresses Th17 cell development in an IL-2-dependent but Tim-3-independent manner. | 1.12e-04 | 3 | 213 | 2 | 22341088 | |
| Pubmed | 1.12e-04 | 3 | 213 | 2 | 32380082 | ||
| Pubmed | 1.12e-04 | 3 | 213 | 2 | 23667648 | ||
| Pubmed | 1.12e-04 | 3 | 213 | 2 | 28877989 | ||
| Pubmed | 1.12e-04 | 3 | 213 | 2 | 19800850 | ||
| Pubmed | 1.12e-04 | 3 | 213 | 2 | 38987795 | ||
| Pubmed | 1.12e-04 | 3 | 213 | 2 | 9971820 | ||
| Pubmed | 1.12e-04 | 3 | 213 | 2 | 37105392 | ||
| Pubmed | 1.12e-04 | 3 | 213 | 2 | 37876819 | ||
| Pubmed | 1.12e-04 | 3 | 213 | 2 | 35982159 | ||
| Pubmed | 1.12e-04 | 3 | 213 | 2 | 36479526 | ||
| Interaction | PHF21A interactions | HIVEP1 ACACA MYCBP2 BIRC6 PHF21A TAF1 ARHGAP21 CSTPP1 NPAT HDAC5 JMJD1C DENND4C EGR2 PPM1F ZNF516 | 2.65e-06 | 343 | 206 | 15 | int:PHF21A |
| Interaction | KDM1A interactions | NR2C2 HIVEP1 ACACA RAPH1 MYCBP2 RBBP8NL BIRC6 PHF21A ZBP1 AP1G2 TAF1 DNAJA1 ARHGAP21 CSTPP1 NPAT EDC3 HDAC5 PPM1D GEMIN5 RFX1 JMJD1C DENND4C PPM1F KIAA1217 ZNF516 LRP1 | 4.04e-06 | 941 | 206 | 26 | int:KDM1A |
| Interaction | KLF3 interactions | EPC2 NR2C2 HIVEP1 GATAD2B PHF21A TAF1 SAP130 PITRM1 RFX7 JMJD1C ZNF516 ELF1 | 4.21e-06 | 228 | 206 | 12 | int:KLF3 |
| Interaction | HDAC1 interactions | NR2C2 HIVEP1 ACACA RAPH1 MYCBP2 BIRC6 GATAD2B PHF21A RNF157 SYNE2 TAF1 DNAJA1 SAP130 ARHGAP21 CSTPP1 NPAT HDAC5 RBL1 GEMIN5 RFX1 CREM JMJD1C DENND4C TRAK1 EEF1A2 ZNF827 PPM1F ZNF516 | 8.99e-06 | 1108 | 206 | 28 | int:HDAC1 |
| Interaction | RCOR1 interactions | HIVEP1 ACACA RAPH1 MYCBP2 BIRC6 PHF21A TAF1 DNAJA1 ARHGAP21 CSTPP1 NPAT HDAC5 GEMIN5 JMJD1C DENND4C ZNF827 ZNF516 | 1.38e-05 | 494 | 206 | 17 | int:RCOR1 |
| Cytoband | 12q15-q21 | 6.35e-05 | 3 | 212 | 2 | 12q15-q21 | |
| Cytoband | 5p13-p12 | 6.35e-05 | 3 | 212 | 2 | 5p13-p12 | |
| Cytoband | 17q21 | 2.13e-04 | 63 | 212 | 4 | 17q21 | |
| Cytoband | 2q23.1 | 3.14e-04 | 6 | 212 | 2 | 2q23.1 | |
| GeneFamily | Fibronectin type III domain containing | EPHB6 PRTG GHR TYRO3 LRFN2 PTPRB ASTN2 COL14A1 SDK1 SDK2 COL12A1 LIFR TRIM9 | 6.81e-10 | 160 | 148 | 13 | 555 |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | PRTG TYRO3 LRFN2 HMCN2 ALPK3 SDK1 HSPG2 SDK2 MXRA5 HMCN1 KIRREL1 SIGLEC1 | 8.46e-09 | 161 | 148 | 12 | 593 |
| GeneFamily | Immunoglobulin like domain containing | 3.05e-05 | 193 | 148 | 9 | 594 | |
| GeneFamily | Plexins | 4.35e-05 | 9 | 148 | 3 | 683 | |
| GeneFamily | Fibulins | 1.80e-03 | 8 | 148 | 2 | 556 | |
| GeneFamily | Regulatory factor X family | 1.80e-03 | 8 | 148 | 2 | 1153 | |
| GeneFamily | Transglutaminases | 2.31e-03 | 9 | 148 | 2 | 773 | |
| Coexpression | LAKE_ADULT_KIDNEY_C17_COLLECTING_SYSTEM_PCS_STRESSED_DISSOC_SUBSET | HIVEP2 BTBD9 ESYT2 DNAJA1 SDK1 MAML3 RAD51B FRAS1 JMJD1C TRAK1 KIAA1217 MBD5 ZNF292 | 5.03e-08 | 240 | 202 | 13 | M39236 |
| Coexpression | BUSSLINGER_GASTRIC_IMMUNE_CELLS | HIVEP2 KLHL28 MYCBP2 HIPK1 BIRC6 GATAD2B ASAP1 STIM1 CREBRF JARID2 ESYT2 KLRC1 APBB1IP TBCD NPAT SET SCAF8 SMCHD1 NR4A2 RNF213 MED1 RFX7 CREM JMJD1C ANKRD44 PACS1 TRAPPC10 AUTS2 ELF1 EIF3F ZNF292 | 4.64e-07 | 1492 | 202 | 31 | M40023 |
| Coexpression | DESCARTES_FETAL_THYMUS_THYMIC_EPITHELIAL_CELLS | GHR MYO3A FAT2 ASTN2 SDK1 FRAS1 PITRM1 KIAA1549 OTUD7A RASEF | 2.12e-05 | 244 | 202 | 10 | M40312 |
| Coexpression | MURARO_PANCREAS_PANCREATIC_POLYPEPTIDE_CELL | 2.58e-05 | 153 | 202 | 8 | M39171 | |
| Coexpression | ZHENG_BOUND_BY_FOXP3 | HIVEP2 JARID2 ESYT2 SYNE2 APBB1IP RBL1 NR4A2 NOX3 CREM JMJD1C ANKRD44 ZBTB25 ELF1 CDH10 | 3.51e-05 | 498 | 202 | 14 | M1741 |
| Coexpression | ZHENG_BOUND_BY_FOXP3 | HIVEP2 JARID2 ESYT2 SYNE2 APBB1IP RBL1 NR4A2 NOX3 CREM JMJD1C ANKRD44 ZBTB25 ELF1 CDH10 | 4.26e-05 | 507 | 202 | 14 | MM1030 |
| Coexpression | FAN_EMBRYONIC_CTX_EX_4_EXCITATORY_NEURON | 4.62e-05 | 166 | 202 | 8 | M39026 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HGABA | RAPH1 MYCBP2 ASIC2 RNF157 CREBRF FAT2 PLPPR4 PCDH11X TARBP1 TRHDE PLXNA3 PPFIA2 HCN3 KIAA1549 RFX7 EEF1A2 ANKRD44 PACS1 TRIM9 AUTS2 CSMD1 HYDIN | 4.78e-05 | 1106 | 202 | 22 | M39071 |
| Coexpression | ZHONG_PFC_C8_UNKNOWN_NEUROD2_POS_INTERNEURON | 4.80e-05 | 84 | 202 | 6 | M39095 | |
| Coexpression | ZHONG_PFC_C3_ASTROCYTE | RGS11 KIAA0319 PCDH11X AP1G2 PLXNA3 PPFIA2 CNTNAP1 GEMIN5 EEF1A2 ANKRD44 PACS1 AUTS2 | 5.32e-05 | 389 | 202 | 12 | M39102 |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | PCDH11X DNAH9 SDK1 TRHDE OTOA FRAS1 COL12A1 PPFIA2 HMCN1 CSMD1 HYDIN | 9.69e-10 | 184 | 204 | 11 | 2cbed6462fea2622871bb7e49b0df3d984239281 |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | PCDH11X DNAH9 SDK1 TRHDE OTOA FRAS1 COL12A1 PPFIA2 HMCN1 CSMD1 HYDIN | 9.69e-10 | 184 | 204 | 11 | 2b19a8c5f823e00812908b23e66bb4e563278aff |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | PCDH11X DNAH9 SDK1 TRHDE OTOA FRAS1 COL12A1 PPFIA2 HMCN1 CSMD1 HYDIN | 9.69e-10 | 184 | 204 | 11 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 |
| ToppCell | LV-09._Endothelium_I|LV / Chamber and Cluster_Paper | CPAMD8 ASAP1 PTPRB SYNE2 PLCB1 TBCD HSPG2 KIAA1549 LIFR HMCN1 KIAA1217 | 1.99e-09 | 197 | 204 | 11 | f9731d4d636e51b94a96805eee6afe9aedc175e3 |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-1|TCGA-Pancreas / Sample_Type by Project: Shred V9 | NBEAL1 BIRC6 OSBPL11 TAF1 SAP130 NPAT WWP1 SMCHD1 MED1 HMCN1 | 1.57e-08 | 186 | 204 | 10 | 03db813598b67b1e08f759758a1c2023396921fa |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | CPAMD8 ASIC2 SYNE2 PLCB1 ASTN2 ADGRF1 TRHDE RNF213 KIRREL1 HYDIN | 2.35e-08 | 194 | 204 | 10 | e577d9e88390b36b5a09b97fe1026089892275a3 |
| ToppCell | Bronchial-NucSeq|Bronchial / Cell types per location group and 10X technology with lineage, and cell group designations | ACACA BTBD9 SDK1 MAML3 RAD51B AMBRA1 RFX7 ANKRD44 AUTS2 MBD5 | 2.59e-08 | 196 | 204 | 10 | ab53c742866945545a92e2e61850d63c80d9a2a6 |
| ToppCell | Tracheal-NucSeq|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations | 2.99e-08 | 199 | 204 | 10 | 94b94b17ca18b8dc27b91da1f2ccf89e03cc7035 | |
| ToppCell | TCGA-Ovary-Primary_Tumor-Ovarian_Carcinoma-Serous_Cystadenocarcinoma-5|TCGA-Ovary / Sample_Type by Project: Shred V9 | 7.77e-08 | 166 | 204 | 9 | 32d2eaf8a5d03881bf74d680825af2d5110b082d | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D231|Adult / Lineage, Cell type, age group and donor | 9.53e-08 | 170 | 204 | 9 | 269dee5abca9f6aa079f116f0d8f1d198604d9d4 | |
| ToppCell | renal_papilla_nuclei|World / Celltypes from Cells and Nuclei per compartment and clinical group | 1.55e-07 | 180 | 204 | 9 | 49829e833fe6d2431cfd2e8f378c2aaa3b2b46a4 | |
| ToppCell | Children_(3_yrs)-Endothelial-endothelial_cell_of_artery-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.96e-07 | 185 | 204 | 9 | a7ae76058b2082020cadec49d63b9f4e24d21734 | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 2.24e-07 | 188 | 204 | 9 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference|renal_medulla_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group | 2.45e-07 | 190 | 204 | 9 | f1363f7806cfc4f14fbc1b0e8dac2de813a88eee | |
| ToppCell | Children_(3_yrs)-Endothelial-endothelial_cell_of_artery|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.45e-07 | 190 | 204 | 9 | f6c38d197fd9d69a4f97cb2e72cd4747984c1a86 | |
| ToppCell | nucseq|World / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.80e-07 | 193 | 204 | 9 | 779276e775cb2492e8dd36436295a536084a6415 | |
| ToppCell | 10x5'v1-week_12-13-Mesenchymal_adipo|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 2.80e-07 | 193 | 204 | 9 | 6ef9007c9d18fb775d08fb20cdf954a28d54d7eb | |
| ToppCell | 10x5'v1-week_12-13-Mesenchymal_adipo-stroma-adipo-CAR|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 2.80e-07 | 193 | 204 | 9 | e4ea7ce011a80b81b841c907719aa532bed39d2e | |
| ToppCell | 10x5'v1-week_12-13-Mesenchymal_adipo-stroma|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 2.80e-07 | 193 | 204 | 9 | cf2461af78f65616ce40d552ee9452295e3895ed | |
| ToppCell | Smart-seq2-spleen_(Smart-seq2)-myeloid-myeloid_granulocytic|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 3.06e-07 | 195 | 204 | 9 | 19853c654ac64b3ae3bc99841c6cb29c8aaba85c | |
| ToppCell | Smart-seq2-spleen_(Smart-seq2)-myeloid-myeloid_granulocytic-neutrophil|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 3.06e-07 | 195 | 204 | 9 | d3755929ebbbf5e3afde44281e9056ddb614a291 | |
| ToppCell | LV-09._Endothelium_I|World / Chamber and Cluster_Paper | 3.06e-07 | 195 | 204 | 9 | 19e0a6c3eae1615aaa39767300acd937dfcb2a7f | |
| ToppCell | Basal_cells|World / lung cells shred on cell class, cell subclass, sample id | 3.33e-07 | 197 | 204 | 9 | 24360b660000bdfb999d58fbf4e29585a97e1785 | |
| ToppCell | 10x_3'_v3-tissue-resident_(10x_3'_v3)-mesenchymal-mesenchymal-mesenchymal_stem_cell|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 3.33e-07 | 197 | 204 | 9 | 3bb92dd8a94e2be3b7fe51c9a21b241215477ac7 | |
| ToppCell | 10x_3'_v3-tissue-resident_(10x_3'_v3)-mesenchymal|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 3.33e-07 | 197 | 204 | 9 | 17344464fdcc5ba0c03959696b97c195f11e644c | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-Pericyte-F|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.33e-07 | 197 | 204 | 9 | 2872a78b1be61aa1d50bc9a49294a21e922dc033 | |
| ToppCell | 10x_3'_v3-tissue-resident_(10x_3'_v3)-mesenchymal-mesenchymal|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 3.33e-07 | 197 | 204 | 9 | 5b8d0d7116b20d8e27541e88ec80c9f1f477e384 | |
| ToppCell | Bronchus_Control_(B.)-Immune-TX-B_cells|Bronchus_Control_(B.) / Sample group, Lineage and Cell type | MYCBP2 CREBRF DNAJA1 APBB1IP SMCHD1 NR4A2 RAB11FIP1 ANKRD44 ELF1 | 3.48e-07 | 198 | 204 | 9 | 6231c44a909dd06f85c8210814e976a5f29148d0 |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | MYCBP2 BIRC6 SYNE2 SMCHD1 RNF213 JMJD1C ANKRD44 SIGLEC1 ZNF292 | 3.78e-07 | 200 | 204 | 9 | 12f1685ce8f218433068e090c9d839cd5a1910bf |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.78e-07 | 200 | 204 | 9 | b4ccffdd79526c85e5273d27b668dbddcddba1ee | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | BIRC6 PTPRB SYNE2 COL12A1 RNF213 FAM171A1 LIFR HMCN1 KIAA1217 | 3.78e-07 | 200 | 204 | 9 | dccec522ab0d7fff62ad6273b02aa9022dbbb8eb |
| ToppCell | normal_Lung-Fibroblasts-Myofibroblasts|Fibroblasts / Location, Cell class and cell subclass | 9.28e-07 | 164 | 204 | 8 | 9b4a6007abae992db871d9f6f731d5af724de30d | |
| ToppCell | facs-Marrow-B-cells-24m-Myeloid-granulocyte_monocyte_progenitor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.72e-07 | 165 | 204 | 8 | 6d315e0734079ad05336cc2c3f24d870c9105bc8 | |
| ToppCell | facs-Marrow-B-cells-24m-Myeloid-granulocyte_monocyte_progenitor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.72e-07 | 165 | 204 | 8 | 84f5597b1bb75f42de9a224196bb8ac198bbe3bf | |
| ToppCell | facs-Pancreas-Exocrine-3m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.45e-06 | 174 | 204 | 8 | f1fe1f4216748a9562dd03bd48c70b23c7ff4d1d | |
| ToppCell | Adult-Endothelial-endothelial_cell_of_artery-D175|Adult / Lineage, Cell type, age group and donor | 1.51e-06 | 175 | 204 | 8 | 0a65ddfa8c2e8efb5b5338cf07661cb78157a23c | |
| ToppCell | facs-Marrow-B-cells-24m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.51e-06 | 175 | 204 | 8 | 887e75fc90e59a6394d62f3c048a9cfdf6707725 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.65e-06 | 177 | 204 | 8 | bde307e67ad8e48a5ff4c0827015f4688f6b3e46 | |
| ToppCell | droplet-Lung-21m-Epithelial-airway_epithelial-lung_ciliated_cell-ciliated_cell|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.65e-06 | 177 | 204 | 8 | d5640f0097878f0dac671e51dc51310278bb2682 | |
| ToppCell | droplet-Lung-21m-Epithelial-airway_epithelial-lung_ciliated_cell|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.65e-06 | 177 | 204 | 8 | d947ba38db1772fc5fdcdc211f7511c4aa699dee | |
| ToppCell | TCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma-Rectal_Adenocarcinoma-7|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 1.72e-06 | 178 | 204 | 8 | edc76b8f15056ec1c9a1c61a048b6331a92592d6 | |
| ToppCell | 10x3'2.3-week_12-13-Mesenchymal_myocytic-stroma-muscle_stem_cell|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.72e-06 | 178 | 204 | 8 | 8f31b3fac51591f7f2bcb898c07708b3e9f93a16 | |
| ToppCell | Control-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.80e-06 | 125 | 204 | 7 | b162a5bfbb8ac5e65e13578fef9de442a9e4fd8b | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Epithelial-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.20e-06 | 184 | 204 | 8 | 264e14aa1859cfc0ed5fb40e97ea189aed9ef4a5 | |
| ToppCell | COVID-19-Endothelial_cells-Arterial_endothelial_cells|COVID-19 / group, cell type (main and fine annotations) | 2.20e-06 | 184 | 204 | 8 | 0f19494789f38ab1a420545e15e748ca7eb345c3 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Epithelial|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.20e-06 | 184 | 204 | 8 | d7eccbd21c480d907fdc8eff2bf5ae22ae452221 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Epithelial-neuroepithelial_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.20e-06 | 184 | 204 | 8 | 22010cfe0428ebfa40952cc1a1a12ad3d25b35c9 | |
| ToppCell | normal_Lung-Fibroblasts-Myofibroblasts|normal_Lung / Location, Cell class and cell subclass | 2.20e-06 | 184 | 204 | 8 | 0b336489c10e8c3c957795dd845454f03404382b | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)|Adult / Lineage, Cell type, age group and donor | 2.29e-06 | 185 | 204 | 8 | 673f0c688ae6984bc8027df2da335787924f4137 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-24m-Epithelial-neuroepithelial_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.29e-06 | 185 | 204 | 8 | 05bc89a566b0db90ae06506e067190a4739a0974 | |
| ToppCell | 3'-Broncho-tracheal-Immune_Lymphocytic-Lymphocytic_B-B_cell-B_cells-B_cells_L.1.5.0.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.29e-06 | 185 | 204 | 8 | e913c64f9b4873443d88dce270f0b7b6d1b4cbce | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_NK-NK_dim-male|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 2.48e-06 | 187 | 204 | 8 | 0bca79cea4886b66350c56c61859bd71e1e7a85c | |
| ToppCell | TCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma-Colon_Adenocarcinoma-7|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 2.58e-06 | 188 | 204 | 8 | 14bc73cf79c79c9f208369fd8d498e5b26e0114d | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_pro-infl_II-Z|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.79e-06 | 190 | 204 | 8 | 4d401b73c0e7eb38e95d0851a128bf12bb0d3a9f | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-vascular_smooth_muscle_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.79e-06 | 190 | 204 | 8 | d6b3a92119b210974a32af3fe9875d60eb02761e | |
| ToppCell | nucseq-Endothelial-Endothelial_Vascular-Endothelial_large_blood_vessel-AEC|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.90e-06 | 191 | 204 | 8 | 50601ef0a5a8f2c2120922989e08e85bf2d9b4ab | |
| ToppCell | Mesenchymal-vascular_smooth_muscle_cell|World / Lineage, Cell type, age group and donor | 2.90e-06 | 191 | 204 | 8 | fd89fbc62aa1c73e0f659991e3bd726a0c97bd68 | |
| ToppCell | RA-09._Endothelium_I|World / Chamber and Cluster_Paper | 2.90e-06 | 191 | 204 | 8 | c8a0c2af119bc34a8f694a7d30642f28002c84b9 | |
| ToppCell | human_hepatoblastoma-Tumor_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 3.02e-06 | 192 | 204 | 8 | 916fbec1c7ab7969bda711886ac88e877e30c280 | |
| ToppCell | 10x5'-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8|lymph-node_spleen / Manually curated celltypes from each tissue | 3.02e-06 | 192 | 204 | 8 | 47646d7e4990be85072987f92bf18d52f8da752e | |
| ToppCell | facs-Lung-nan-3m-Endothelial-Capillary_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.02e-06 | 192 | 204 | 8 | 4bab9754cfd8b9c2d7cc1490e8a29f58c3c26f6c | |
| ToppCell | 3'-Broncho-tracheal-Immune_Lymphocytic-Lymphocytic_T/NK|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.02e-06 | 192 | 204 | 8 | dceb8b38c2ddb1a848132bd52edc8e883e7d2aa9 | |
| ToppCell | RV-10._Endothelium_II|World / Chamber and Cluster_Paper | 3.13e-06 | 193 | 204 | 8 | 2531266bc57339d4e2b22a88817008e32b8c1598 | |
| ToppCell | human_hepatoblastoma|World / Sample and Cell Type and Tumor Cluster (all cells) | 3.13e-06 | 193 | 204 | 8 | e6a688bc834f845ff64dae1be64f073eec5091a1 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.13e-06 | 193 | 204 | 8 | 42df7ed37d11fb542b4d1d714b6f87ae8e1396a6 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.13e-06 | 193 | 204 | 8 | f42a0f02ed00fe1bb833ff0a0640d9131bca89bd | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.26e-06 | 194 | 204 | 8 | 4579b4a44f7c731553a284843c296866027d7c0e | |
| ToppCell | TCGA-Mesothelium-Primary_Tumor-Mesothelioma-Epitheliod-3|TCGA-Mesothelium / Sample_Type by Project: Shred V9 | 3.32e-06 | 137 | 204 | 7 | a1e34ebbeda3d5a4f14917282d44fcb4dcbf3133 | |
| ToppCell | IPF-Multiplet-Multiplet|IPF / Disease state, Lineage and Cell class | 3.38e-06 | 195 | 204 | 8 | fce0c29574bb7aab181b9c00feb42681e285d1f2 | |
| ToppCell | LA-09._Endothelium_I|World / Chamber and Cluster_Paper | 3.38e-06 | 195 | 204 | 8 | fc95457a298b5d0dab687d9ee7e225a7f7b9a0d4 | |
| ToppCell | IPF-Multiplet|IPF / Disease state, Lineage and Cell class | 3.38e-06 | 195 | 204 | 8 | eacc0449ae6f3ad8002268cd061467684c6fb9a7 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.38e-06 | 195 | 204 | 8 | 3d6d3de8ada6dce3dc789c15b50cc066e7100496 | |
| ToppCell | IPF-Multiplet-Multiplet|World / Disease state, Lineage and Cell class | 3.38e-06 | 195 | 204 | 8 | 21dbdc803c6947024dc2416e9e21c2ef0af9bc31 | |
| ToppCell | background-Endothelial_cells|background / Sample and Cell Type and Tumor Cluster (all cells) | 3.51e-06 | 196 | 204 | 8 | e6fb0bfab1779ec64a8c35d01519eaafbf62e977 | |
| ToppCell | IPF-Epithelial|IPF / Disease state, Lineage and Cell class | 3.51e-06 | 196 | 204 | 8 | 87d9881cfec461a5d89b688a83749b618c519485 | |
| ToppCell | 10x5'v1-week_12-13-Mesenchymal_osteo-stroma-osteoblast_precursor|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 3.65e-06 | 197 | 204 | 8 | 2f72fd9a5b6d62c24a95ed2246194ea7458c0f12 | |
| ToppCell | COVID-19_Mild|World / Disease group, lineage and cell class | 3.65e-06 | 197 | 204 | 8 | 5c33454b10023decd2f5ccda9229b6512659711e | |
| ToppCell | COVID-19-lung-Fibroblast|lung / Disease (COVID-19 only), tissue and cell type | 3.79e-06 | 198 | 204 | 8 | df3de77216f5c5d6141ec44d01c56b942f611838 | |
| ToppCell | PBMC-Mild|PBMC / Location, Disease Group, Cell group, Cell class (2021.03.09) | 3.79e-06 | 198 | 204 | 8 | 44417089b62056269cac38d3134ff209c05b7007 | |
| ToppCell | Parenchymal-NucSeq|Parenchymal / Cell types per location group and 10X technology with lineage, and cell group designations | 3.79e-06 | 198 | 204 | 8 | 1996373bdccc55aac347d349bd22f6aad6d0c668 | |
| ToppCell | (5)_Fibroblasts-(5)_Fibroblast-B_(Myofibroblast)|(5)_Fibroblasts / Lung cell shreds - cell class (v4) and cell subclass (v4) | 3.79e-06 | 198 | 204 | 8 | 196257c4420ac801ed9fbb444f11718adb7560ae | |
| ToppCell | PBMC-Mild|PBMC / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.79e-06 | 198 | 204 | 8 | 28ef3fc4c17dcb765537b75917f7db78baa522db | |
| ToppCell | 10x5'v1-week_12-13-Mesenchymal_osteo|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 3.93e-06 | 199 | 204 | 8 | bf138cc692df727e087d140c014149ee5da00d9d | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Lymphoid-CD4/CD8-CD4_INF-Z|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.93e-06 | 199 | 204 | 8 | d3f36ede2fade550ec8f21a0448e71e1ff579ee2 | |
| ToppCell | 10x5'v1-week_12-13-Mesenchymal_osteo-stroma|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 3.93e-06 | 199 | 204 | 8 | d65ee89d5c7e8ed693d58e6a6de09565840e11c5 | |
| ToppCell | Biopsy_Control_(H.)-Mesenchymal-Myofibroblasts|Biopsy_Control_(H.) / Sample group, Lineage and Cell type | 3.93e-06 | 199 | 204 | 8 | 7a227c239afdaebcac84644d9b2653a5f1a4be71 | |
| ToppCell | control-Epithelial-Secretory|control / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 3.93e-06 | 199 | 204 | 8 | 262e5b8a52c8ddb0b47048c786e8bdb7158e1b9a | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 4.08e-06 | 200 | 204 | 8 | 9b0916d8d07ac2bf1739f7be5296bf77ffee6094 | |
| ToppCell | Bronchial-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.08e-06 | 200 | 204 | 8 | 389cc775c8419d90fb77cd794376d2160a7bf44e | |
| ToppCell | Tracheal-NucSeq-Epithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.08e-06 | 200 | 204 | 8 | d3af0a706baf66e3f32e67b17dcfc31e5b32ce0e | |
| ToppCell | Bronchial-NucSeq-Stromal-Chondrocytic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.08e-06 | 200 | 204 | 8 | b7b9441fa7ab0d43741a2ebd5ec1a48d537c6d47 | |
| ToppCell | Parenchymal-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.08e-06 | 200 | 204 | 8 | cf433f9b43d7db07acaf70e060f8f77c974e72f3 | |
| ToppCell | LPS_only-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_only / Treatment groups by lineage, cell group, cell type | 4.08e-06 | 200 | 204 | 8 | a7ef7022b8efcaedb7319b0b43d8c4e99d788fe2 | |
| ToppCell | Bronchial-NucSeq-Stromal-Chondrocytic-Chondrocyte|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.08e-06 | 200 | 204 | 8 | 7c673ad0ea503ebd196579684d25d5f9e6a41030 | |
| ToppCell | tumor_Lymph_Node_/_Brain-Fibroblasts|tumor_Lymph_Node_/_Brain / Location, Cell class and cell subclass | 4.08e-06 | 200 | 204 | 8 | 4f7e26b27bd51c32420ed8c2f52d070aee542159 | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.08e-06 | 200 | 204 | 8 | cae972324d1dfea6efeaf6013f265c7c6bb48db4 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.08e-06 | 200 | 204 | 8 | 311fab076f2ceb258e3970eb21e39344b894042a | |
| ToppCell | 10x5'-bone_marrow-Lymphocytic_T_CD4-T_CD4/CD8|bone_marrow / Manually curated celltypes from each tissue | 7.82e-06 | 156 | 204 | 7 | 1545169694f686d28648a68b552c2ae606599d66 | |
| ToppCell | Basal_cells-HP_01|World / lung cells shred on cell class, cell subclass, sample id | 8.50e-06 | 158 | 204 | 7 | 51e3ed1b91b010404d66e3e7efdbffc0c815e25b | |
| ToppCell | TCGA-Bladder-Primary_Tumor-Urothelial_Carcinoma-Papillary_Muscle_Invasive_Urothelial_Carcinoma|TCGA-Bladder / Sample_Type by Project: Shred V9 | 8.50e-06 | 158 | 204 | 7 | dc559503bab3ec1b9ea54ef2e896d1be33e5344c | |
| Disease | Alzheimer's disease (implicated_via_orthology) | 2.31e-06 | 57 | 198 | 6 | DOID:10652 (implicated_via_orthology) | |
| Disease | Schizophrenia | CHAT BTBD9 CFAP65 JARID2 PLCB1 ASTN2 NPAS2 DDR1 NR4A2 AMBRA1 TRAK1 LIFR SLC12A2 EGR2 ERVK-8 LRP1 AUTS2 CSMD1 | 3.11e-05 | 883 | 198 | 18 | C0036341 |
| Disease | 1-stearoylglycerol 1-monostearin measurement | 4.48e-05 | 2 | 198 | 2 | EFO_0021111 | |
| Disease | Intellectual Disability | HIVEP2 PEX6 PHF21A TAF1 TBCD SET PITRM1 NR4A2 PACS1 EIF3F MAN1B1 ZNF292 | 5.39e-05 | 447 | 198 | 12 | C3714756 |
| Disease | Autistic Disorder | 7.25e-05 | 261 | 198 | 9 | C0004352 | |
| Disease | Congenital hypomyelinating neuropathy | 1.34e-04 | 3 | 198 | 2 | cv:C0393818 | |
| Disease | autosomal dominant intellectual developmental disorder (implicated_via_orthology) | 1.34e-04 | 3 | 198 | 2 | DOID:0060307 (implicated_via_orthology) | |
| Disease | Schwartz-Jampel syndrome | 1.34e-04 | 3 | 198 | 2 | cv:C0036391 | |
| Disease | PR interval | MYCBP2 ASIC2 CREBRF MYO3A KCND3 SYNE2 ALPK3 ASTN2 EME2 HSPG2 TRAK1 OTUD7A | 1.41e-04 | 495 | 198 | 12 | EFO_0004462 |
| Disease | autosomal dominant intellectual developmental disorder (is_implicated_in) | 1.89e-04 | 17 | 198 | 3 | DOID:0060307 (is_implicated_in) | |
| Disease | Congenital myotonia | 2.66e-04 | 4 | 198 | 2 | cv:CN295225 | |
| Disease | cognitive function measurement | HIVEP1 ASIC2 BIRC6 GATAD2B MYO3A LRFN2 PLCB1 SDK1 MAML3 ARHGAP21 NPAS2 RAD51B PPFIA2 NOX3 JMJD1C TSKU SLC9A4 KIAA1217 PAXIP1 AUTS2 LTBP1 HYDIN | 2.70e-04 | 1434 | 198 | 22 | EFO_0008354 |
| Disease | nevus count, cutaneous melanoma | 3.77e-04 | 91 | 198 | 5 | EFO_0000389, EFO_0004632 | |
| Disease | gamma-glutamylglutamine measurement | 4.17e-04 | 22 | 198 | 3 | EFO_0021138 | |
| Disease | quality of life during menstruation measurement | 4.42e-04 | 5 | 198 | 2 | EFO_0009366 | |
| Disease | gastroesophageal reflux disease | 6.08e-04 | 101 | 198 | 5 | EFO_0003948 | |
| Disease | lymphocyte count | HIVEP1 EPPK1 ACACA RAPH1 ASIC2 JARID2 PLCB1 APBB1IP RAD51B FRAS1 RBL1 RFX7 JMJD1C SLC9A4 EGR2 ZBTB25 AUTS2 KIRREL1 ELF1 SIGLEC1 PHTF1 | 8.88e-04 | 1464 | 198 | 21 | EFO_0004587 |
| Disease | Common Migraine | 9.20e-04 | 7 | 198 | 2 | C0338480 | |
| Disease | gamma-glutamylmethionine measurement | 9.20e-04 | 7 | 198 | 2 | EFO_0021141 | |
| Disease | atrial fibrillation | 9.55e-04 | 371 | 198 | 9 | EFO_0000275 | |
| Disease | Strabismus | 9.56e-04 | 29 | 198 | 3 | HP_0000486 | |
| Disease | Colorectal Carcinoma | EPHB6 CPAMD8 ACACA KCND3 PCDH11X PMS2 NR4A2 ABCB6 LIFR PPM1F LRP1 IGSF21 ZNF292 | 9.74e-04 | 702 | 198 | 13 | C0009402 |
| Disease | Breast Cancer, Familial | 1.06e-03 | 30 | 198 | 3 | C0346153 | |
| Disease | schizophrenia (implicated_via_orthology) | 1.15e-03 | 68 | 198 | 4 | DOID:5419 (implicated_via_orthology) | |
| Disease | atypical femoral fracture, response to bisphosphonate | 1.15e-03 | 68 | 198 | 4 | EFO_0009958, EFO_0009960 | |
| Disease | C-C motif chemokine 5 measurement | 1.22e-03 | 8 | 198 | 2 | EFO_0008053 | |
| Disease | Attached earlobe | 1.22e-03 | 8 | 198 | 2 | HP_0009907 | |
| Disease | P wave terminal force measurement | 1.22e-03 | 8 | 198 | 2 | EFO_0008379 | |
| Disease | Major Depressive Disorder | 1.33e-03 | 243 | 198 | 7 | C1269683 | |
| Disease | juvenile idiopathic arthritis | 1.57e-03 | 74 | 198 | 4 | EFO_0002609 | |
| Disease | Unipolar Depression | 1.90e-03 | 259 | 198 | 7 | C0041696 | |
| Disease | Polyarthritis, Juvenile, Rheumatoid Factor Positive | 1.94e-03 | 131 | 198 | 5 | C4704862 | |
| Disease | Polyarthritis, Juvenile, Rheumatoid Factor Negative | 1.94e-03 | 131 | 198 | 5 | C4552091 | |
| Disease | Juvenile arthritis | 1.94e-03 | 131 | 198 | 5 | C3495559 | |
| Disease | Juvenile psoriatic arthritis | 1.94e-03 | 131 | 198 | 5 | C3714758 | |
| Disease | response to carboplatin, response to antineoplastic agent | 1.95e-03 | 10 | 198 | 2 | GO_0097327, GO_0097328 | |
| Disease | glucagon-like peptide-1 measurement | 1.95e-03 | 10 | 198 | 2 | EFO_0008465 | |
| Disease | Juvenile-Onset Still Disease | 2.22e-03 | 135 | 198 | 5 | C0087031 | |
| Disease | interleukin 1 receptor-like 1 measurement | 2.37e-03 | 11 | 198 | 2 | EFO_0008168 | |
| Disease | peptidyl-glycine alpha-amidating monooxygenase measurement | 2.37e-03 | 11 | 198 | 2 | EFO_0801871 | |
| Disease | alpha peak frequency measurement, alpha wave measurement, electroencephalogram measurement | 2.37e-03 | 11 | 198 | 2 | EFO_0004357, EFO_0006870, EFO_0006883 | |
| Disease | osteosarcoma (is_marker_for) | 2.37e-03 | 11 | 198 | 2 | DOID:3347 (is_marker_for) | |
| Disease | Situs Inversus | 2.37e-03 | 11 | 198 | 2 | C0037221 | |
| Disease | Malignant neoplasm of breast | PRRG1 RAPH1 SYNE2 OSBPL11 PLCB1 ASTN2 HERC2 DNAH9 PLXNB1 RAD51B GPER1 PPM1D ABCB6 PPM1F USP54 CDH10 | 2.52e-03 | 1074 | 198 | 16 | C0006142 |
| Disease | wellbeing measurement | HIVEP1 HIVEP2 GATAD2B PHF21A SDK1 MAML3 TRHDE NR4A2 NOX3 AUTS2 RASEF PHTF1 | 2.61e-03 | 692 | 198 | 12 | EFO_0007869 |
| Disease | response to radiation | 2.96e-03 | 88 | 198 | 4 | GO_0009314 | |
| Disease | cognitive impairment measurement | 3.22e-03 | 44 | 198 | 3 | EFO_0007998 | |
| Disease | unipolar depression | HIVEP2 ASIC2 SYNE2 ALPK3 ASTN2 ARHGEF37 SDK1 MAML3 OTOA CNTNAP1 NR4A2 RNF213 ANKRD44 AUTS2 EIF3F CSMD1 CD276 | 3.28e-03 | 1206 | 198 | 17 | EFO_0003761 |
| Disease | aspartate aminotransferase measurement, serum alanine aminotransferase measurement, low density lipoprotein triglyceride measurement, body fat percentage, high density lipoprotein cholesterol measurement, sex hormone-binding globulin measurement | 3.33e-03 | 364 | 198 | 8 | EFO_0004612, EFO_0004696, EFO_0004735, EFO_0004736, EFO_0007800, EFO_0009946 | |
| Disease | juvenile polyposis syndrome (implicated_via_orthology) | 3.33e-03 | 13 | 198 | 2 | DOID:0050787 (implicated_via_orthology) | |
| Disease | severe acute respiratory syndrome, COVID-19 | JARID2 KCND3 PCDH11X OSBPL11 PMS2 MXRA5 KIAA1217 AUTS2 CSMD1 | 3.37e-03 | 447 | 198 | 9 | EFO_0000694, MONDO_0100096 |
| Disease | obesity (implicated_via_orthology) | 3.40e-03 | 215 | 198 | 6 | DOID:9970 (implicated_via_orthology) | |
| Disease | diabetic nephropathy | 3.49e-03 | 150 | 198 | 5 | EFO_0000401 | |
| Disease | Neurodevelopmental Disorders | 3.61e-03 | 93 | 198 | 4 | C1535926 | |
| Disease | selective IgA deficiency disease | 3.65e-03 | 46 | 198 | 3 | EFO_1001929 | |
| Disease | heart rate variability measurement, response to antipsychotic drug | 3.65e-03 | 46 | 198 | 3 | EFO_0008003, GO_0097332 | |
| Disease | early cardiac repolarization measurement | 3.87e-03 | 14 | 198 | 2 | EFO_0004885 | |
| Disease | waist-hip ratio | CPAMD8 MYCBP2 BIRC6 RNF157 CFAP65 LRFN2 SYNE2 ASTN2 COL14A1 MAML3 ARHGAP21 NPAS2 RAD51B SMCHD1 RFX7 JMJD1C KY | 3.87e-03 | 1226 | 198 | 17 | EFO_0004343 |
| Disease | multisite chronic pain | 3.89e-03 | 95 | 198 | 4 | EFO_0010100 | |
| Disease | glucagon measurement | 3.90e-03 | 154 | 198 | 5 | EFO_0008463 | |
| Disease | FEV/FEC ratio | HIVEP2 ASAP1 STIM1 SYNE2 ASTN2 RAD51B HSPG2 FRAS1 ZNF781 SCAF8 JMJD1C HMCN1 ZNF516 LRP1 LTBP1 CSMD1 CD276 | 3.93e-03 | 1228 | 198 | 17 | EFO_0004713 |
| Disease | venous thromboembolism | PHF21A ASTN2 CSTPP1 GEMIN5 AMBRA1 INTS10 OTUD7A IGSF21 PRDM15 | 4.06e-03 | 460 | 198 | 9 | EFO_0004286 |
| Disease | Paroxysmal atrial fibrillation | 4.12e-03 | 156 | 198 | 5 | C0235480 | |
| Disease | familial atrial fibrillation | 4.12e-03 | 156 | 198 | 5 | C3468561 | |
| Disease | Persistent atrial fibrillation | 4.12e-03 | 156 | 198 | 5 | C2585653 | |
| Disease | Hepatic fibrosis | 4.37e-03 | 49 | 198 | 3 | HP_0001395 | |
| Disease | Atrial Fibrillation | 4.59e-03 | 160 | 198 | 5 | C0004238 | |
| Disease | dyslexia | 4.83e-03 | 162 | 198 | 5 | EFO_0005424 | |
| Disease | circadian rhythm | 4.96e-03 | 163 | 198 | 5 | EFO_0004354 | |
| Disease | malaria | 5.01e-03 | 102 | 198 | 4 | EFO_0001068 | |
| Disease | Abnormal behavior | 5.05e-03 | 16 | 198 | 2 | C0233514 | |
| Disease | migraine without aura, susceptibility to, 4 | 5.05e-03 | 16 | 198 | 2 | MONDO_0011847 | |
| Disease | body weight | HIVEP1 HIVEP2 NBEAL1 RIPK2 PHF21A GHR LRFN2 KCND3 ASTN2 ITIH6 MAML3 SMCHD1 NR4A2 SLC12A2 KIAA1217 AUTS2 LTBP1 | 5.10e-03 | 1261 | 198 | 17 | EFO_0004338 |
| Disease | neuroticism measurement, cognitive function measurement | HIVEP1 NBEAL1 BIRC6 NPAS2 TRHDE NOX3 JMJD1C KIAA1217 AUTS2 CSMD1 | 5.12e-03 | 566 | 198 | 10 | EFO_0007660, EFO_0008354 |
| Disease | Bipolar Disorder | 5.13e-03 | 477 | 198 | 9 | C0005586 | |
| Disease | monoclonal gammopathy | 5.45e-03 | 53 | 198 | 3 | EFO_0000203 | |
| Disease | aspartate aminotransferase to alanine aminotransferase ratio | 5.67e-03 | 239 | 198 | 6 | EFO_0010934 | |
| Disease | Moyamoya Disease | 5.70e-03 | 17 | 198 | 2 | C0026654 | |
| Disease | phosphatidylcholine 40:6 measurement | 5.70e-03 | 17 | 198 | 2 | EFO_0010389 | |
| Disease | body mass index, osteoarthritis | 5.74e-03 | 54 | 198 | 3 | EFO_0004340, MONDO_0005178 | |
| Disease | factor VII measurement | 6.04e-03 | 55 | 198 | 3 | EFO_0004619 | |
| Disease | glucose homeostasis measurement, acute insulin response measurement | 6.39e-03 | 18 | 198 | 2 | EFO_0006831, EFO_0006896 | |
| Disease | Ischemic stroke | 6.47e-03 | 324 | 198 | 7 | HP_0002140 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| IPLTIVVGNRSHVSS | 641 | Q9UKU6 | |
| PLGQIQLTIRHSSQR | 786 | A0FGR8 | |
| PLRGDAQISVTLVNH | 486 | P16452 | |
| VSVVSPVNVHINTRT | 736 | Q52LR7 | |
| HLPVTQVVIGDTNRS | 751 | P78357 | |
| VSPRNQQLHTVTLQT | 431 | P32519 | |
| HETRGQNSNALPSVL | 4346 | Q9NR09 | |
| PLLVVLSGNHTEQSN | 2386 | Q96PZ7 | |
| SVIIRQNPSTTVGNL | 331 | Q5T601 | |
| RSSHEVSLQAGQPVT | 616 | A1IGU5 | |
| QQSRPLLSQIHTDAA | 246 | Q8IUR6 | |
| LQTLRTAQPIIGTTH | 206 | Q6PIY5 | |
| VHLSVPGDTILINNR | 461 | Q08345 | |
| NGQIPQATHSVSAVL | 466 | Q7Z5R6 | |
| VVTASRNHEQTVLGP | 981 | Q96L96 | |
| HSISGVSDPFLQVQI | 236 | O75843 | |
| QVTQASLRSHIGVVP | 656 | Q9NP58 | |
| ERGQVLPAHTLLNTV | 656 | Q13085 | |
| VQQAELHTGSLPRIQ | 826 | Q13085 | |
| AQLHVTPGSAQQRFT | 66 | Q92843 | |
| HINPTGTVLLQLENT | 406 | P06280 | |
| RNPVLQQDAHGSVTI | 441 | Q5ZPR3 | |
| QPGLATHSSVNRVLA | 826 | Q9C0C7 | |
| DNRTIVITSHPGQIV | 281 | P31689 | |
| VTDVHIPQNGSRALL | 81 | Q8N4T0 | |
| LSGSIDHQTSVQQLP | 26 | P26436 | |
| SRLQTHNSVIGVPIR | 271 | O75129 | |
| HLRGTSTETVPNANI | 1071 | Q06278 | |
| TISHTVNVPLQTTLG | 491 | Q16515 | |
| RVEPFTTLHIQLQSG | 2111 | Q6ZS30 | |
| VVIPSTLIQRHNNSS | 91 | P26715 | |
| IPVILTNQITTHLSG | 251 | O15315 | |
| TQPAGHVRSQSIVSS | 561 | Q70E73 | |
| GSIHVISRDQSTPII | 341 | P49116 | |
| VLVTIQQRLSGSHSQ | 2516 | P98160 | |
| LHINNISPGNTISRS | 371 | Q8IZ41 | |
| QRLLVTVIPHAVTGS | 41 | O94810 | |
| PVTLSGFVHQLSDNI | 11 | P11161 | |
| HLAALQGSISQPQIT | 471 | Q9NVR2 | |
| TTGSQIQHLTQVGIA | 1816 | Q9HCM3 | |
| PGQISSAQVTSQHLL | 586 | Q99743 | |
| LPVSVESSHLNVSGQ | 606 | Q14207 | |
| EVQNAVLVSPSLSGH | 161 | Q9BUJ0 | |
| PTTQISHSQGIRLGV | 396 | Q8N9V6 | |
| NRPSNVAHILQTLSA | 351 | Q6ZW49 | |
| PEAVHGAISTLNQVS | 421 | Q7RTW8 | |
| HGVPETTQSLIQFVR | 1871 | P23467 | |
| VTVPLATQSSLRHNA | 226 | Q5VUB5 | |
| IHIQGSEQPSLTTSR | 576 | Q9UK17 | |
| HVVSTPTNGQLVLSR | 1141 | Q86XX4 | |
| PHSVNSRVFIGNLNT | 11 | B2RXH8 | |
| RLTKQHFPQGLSQSV | 996 | Q96JK9 | |
| VGHARLSRVLNQPQS | 121 | Q93015 | |
| HVTLATAQPLNVGVA | 816 | Q86Z02 | |
| QILSQPAVQETGTVH | 2341 | O95714 | |
| NGQNVTTVSHRGPLL | 4801 | Q8NDA2 | |
| PITQTVIHTVQSASG | 191 | Q6DKI2 | |
| SQGTQLTVEVHPRDA | 86 | Q8NBH2 | |
| SNVQVLHRTGLSNPD | 3091 | Q07954 | |
| SIHSRLVVPGQNVFL | 1426 | Q6ZU64 | |
| QRTVQALLNHGSPTV | 346 | Q6ZVZ8 | |
| TGRIILPNVNSDSVH | 1351 | Q15652 | |
| PITQTVIHTVQSASG | 191 | Q3B8N2 | |
| RADHQVNGSTTLPIS | 316 | Q96DD0 | |
| HSGNITRIRISPGNQ | 586 | Q8N1V2 | |
| VTSPGVQLTVTLHNV | 551 | P51805 | |
| TRVTIRGSNLGQHVQ | 1086 | O43157 | |
| VPQLHRGSTISQSLA | 1621 | Q9ULL4 | |
| LHIRTSPGQASTVVV | 431 | Q9NYQ8 | |
| PLSSQSVVIHHGQTQ | 291 | Q14766 | |
| SSNTSQPHLARVQVL | 231 | Q13608 | |
| RDNTPTVLHGINLTI | 1151 | Q96J66 | |
| LPVNALGHTRSSTEQ | 861 | Q8WXX7 | |
| TSQNSIHPVRVVNGQ | 276 | Q96BD5 | |
| SPATVQSRQGDIHEL | 276 | Q9C075 | |
| LLGHSPVLRNITNSQ | 156 | P30305 | |
| HLVQLVTAASRTPQQ | 371 | Q8N3J3 | |
| GTQSTHESLKPQRVQ | 21 | Q969J5 | |
| NVTKRTPLHASVING | 631 | Q8N8A2 | |
| VSQTISLTRPFHNGV | 31 | Q96F86 | |
| PQNLRTLQGHSVIRS | 236 | Q8WXI9 | |
| PARQSVIHVQASGAR | 766 | Q8TE49 | |
| LTHNGPVRRSTVIDQ | 251 | O15297 | |
| LPQVIALHRSQAQSS | 1261 | Q9BZA7 | |
| VTSNVAIALTHQRGP | 616 | Q9P1Z3 | |
| TRQGARQLHVLVPQS | 521 | O95402 | |
| IFATAHSPTGIIIQN | 341 | P63135 | |
| IFATAHSPTGIIIQN | 341 | Q9BXR3 | |
| EISSQKTQRHIQRGP | 151 | Q9UKM7 | |
| LHAPIVVGTQTRSSA | 576 | O75161 | |
| VQVSRLPHSGEAQLS | 856 | Q6VY07 | |
| PTIQHGQQILSTIEG | 981 | Q96RW7 | |
| INVNTSGRNHAVLPS | 4026 | Q96RW7 | |
| TIIAGPQNITTSLHQ | 236 | Q2VWP7 | |
| IFATAHSPTGIIIQN | 341 | Q9QC07 | |
| PQRISNQLHGTIAVV | 211 | Q8NC74 | |
| HVVSSNSAAPGRQQL | 191 | P83110 | |
| QNPLGSTDTHTRLIV | 416 | Q96ID5 | |
| LPVSGFISSHQEQVL | 1441 | Q4G0P3 | |
| PVHFQTVLGSSQIIL | 4931 | Q4G0P3 | |
| TNVRPGVTIRKHENS | 341 | Q9NXS3 | |
| QTTRSDLQGHQAVPE | 411 | Q9Y5R5 | |
| TVIVPTSSSGQHRQR | 171 | Q9H6J7 | |
| RQHALSVGPQTTTLS | 376 | Q99715 | |
| NPIHLTVDTSLQNGR | 196 | O00303 | |
| LAVLRPHTGNAVTAQ | 6 | Q96MS3 | |
| TSIHIVQSPQGLILN | 596 | P10912 | |
| QNTIHLRVLESSPVG | 271 | Q9Y6N8 | |
| TAILNQIPSHSSSIR | 1636 | Q05707 | |
| TSQVIILNHPGQISA | 341 | Q05639 | |
| RGNIVLSGQQPAHTT | 491 | Q8IZJ3 | |
| PQGIIIVFRLQTHTT | 41 | Q8IU53 | |
| TISVAGINHNITTGR | 401 | O75976 | |
| HGISTVSLPNSLQEV | 1656 | Q5VZ89 | |
| NGILTISHATSNRQP | 351 | Q9ULH1 | |
| SSVLQNIPLRGEAVH | 746 | Q9P267 | |
| TPSVILSNVRQALGH | 406 | Q6UXX5 | |
| TNVSTLVNVHFAPRI | 296 | Q96J84 | |
| LQGVATLTQISGPTH | 151 | A4GXA9 | |
| LSNGTAPQQVQRHLS | 1616 | Q9NYC9 | |
| LSLATVPHQALGRTQ | 646 | Q9UQL6 | |
| SSVETGFNVINHPIR | 106 | Q8IXS0 | |
| QPASFIRIVGTHNTA | 531 | Q96Q07 | |
| TLVQLPSGQTIHVQG | 56 | Q03060 | |
| HQISSGENTRSVIPN | 776 | Q9UPN6 | |
| SEAGAQLHPVITTQS | 2176 | Q7Z5N4 | |
| APRNVVVHGATATQL | 1626 | Q58EX2 | |
| AATGRIQTQHVLSPA | 426 | P55291 | |
| HQDILTSPVSGILNQ | 51 | Q68DL7 | |
| VQPHTVTALRNSEKG | 241 | Q6PJW8 | |
| TASPIILHENNVSRS | 236 | Q15648 | |
| NAHNPLGRSQSTILV | 411 | P42702 | |
| NRTQQIGVLSSHPFE | 601 | O75334 | |
| VVGLVQSHLTRQQGS | 371 | P49593 | |
| VTNHAPLSGESLTQV | 481 | Q9BXB4 | |
| NLTVLPNNTGSILRH | 891 | Q92833 | |
| VRENNSPALHIGSVS | 461 | Q9UN66 | |
| QIGHASQLLDTQVPS | 236 | P43354 | |
| IIQQLATGSQPIHSF | 1241 | P0C091 | |
| SPTHVQVTVLQARGL | 16 | Q6WKZ4 | |
| SETQLSQRPSVQHLG | 456 | Q96PX1 | |
| FGHTSQLVTDIQPVL | 851 | A6NHR9 | |
| VLTGPQQQSHQLVSL | 631 | Q3ZLR7 | |
| ATNHVTEGIPRLDSQ | 396 | O14545 | |
| INSQLARHTSPSVIS | 41 | Q8WXH0 | |
| ISIGPQRHQTTQQIV | 1311 | O15061 | |
| AQEVHSTGINRPKRT | 771 | P28749 | |
| QVSLTVHGTQQVHSP | 191 | P22670 | |
| EQRSGPSVLSQVHLS | 1836 | P21675 | |
| QFTNLQPVAVGHLTT | 1381 | P57071 | |
| VPVVHQVSRASNSIT | 491 | O15197 | |
| QIVISHTSGTVNPTE | 226 | Q9NXP7 | |
| NVFISVHLLQRTQPG | 276 | Q99527 | |
| AQAATHTLVDPITGQ | 321 | P58107 | |
| IHGFTVNQVTSVPEL | 46 | Q5JRX3 | |
| HVLSTAEPTQQVFGI | 91 | Q6UWY2 | |
| STAFSIPHQAQRIQG | 566 | Q6AI14 | |
| VTTFVNHPQVSSLLG | 106 | P0DME0 | |
| LRTGQQVETKSQPHS | 1511 | Q5T5P2 | |
| VTTFVNHPQVSALLG | 96 | Q01105 | |
| IRSHPSLQSEQIGIV | 2481 | O75592 | |
| LLHTASPRVQRQVTS | 4046 | O75592 | |
| QSSVRQRLTEPQHGL | 496 | Q13586 | |
| VRGQTQDSLSLHNIT | 226 | Q9HBY0 | |
| TEAQQTTLHPLVGRV | 21 | Q16586 | |
| GLAVQAVTQHTPRAS | 1281 | Q8IY92 | |
| RLPGHTQDTLVAQNS | 281 | P28329 | |
| HSSQGTLVNNVRLPR | 76 | Q9Y242 | |
| VNSGRAHVPTLTEEQ | 856 | Q9UPV9 | |
| SPTHLIKTRGQQATL | 26 | A0A5A2 | |
| HTNRGTTEPLQISQV | 311 | P24278 | |
| IFATAHSPTGIIIQN | 341 | P63136 | |
| RVSIQSRPGSSQLVH | 521 | Q7Z2D5 | |
| TRLQHVTISQLFAPG | 3456 | Q63HN8 | |
| RDHSNTGTVQTVPLR | 1146 | Q92618 | |
| VRSVGNTLVLHQTAL | 236 | Q8N4P2 | |
| HRQFERTIQTPIGST | 691 | Q5TAP6 | |
| FTVNSNLISHQRLPV | 181 | P17036 | |
| LVQTHTLTSAPGRLQ | 411 | A2A3L6 | |
| IQIGHGNIITRQTVS | 206 | Q9H171 | |
| SRITHQIVDRPGQQT | 371 | O00541 | |
| VHCQIVSTQITRPSG | 141 | Q9UMS5 | |
| SVSQGHRPVINEESL | 241 | O43353 | |
| PILLVRGNHQSVLTF | 1196 | P55011 | |
| LGTQGIHSATPINTQ | 586 | Q9H0E3 | |
| GHRTLSVEPSQQLDT | 1306 | Q8TEQ6 | |
| IFATAHSPTGIIIQN | 341 | P10266 | |
| IFATAHSPTGIIIQN | 341 | P63133 | |
| LNISVGVHPLDSFTQ | 186 | Q9H5H4 | |
| VSVISGPQNTRSSHL | 1606 | O60281 | |
| IFATAHSPTGIIIQN | 341 | Q9UQG0 | |
| VSVNVSSHIGANQPL | 621 | Q2KHR2 | |
| GQATVLAIAPSHTLQ | 706 | Q9BZZ2 | |
| ESHISQSNINGTLVP | 31 | Q9BQ87 | |
| LSHNQLTTVPERLSN | 706 | Q9NYK1 | |
| RTTPAENGVNHTTTL | 856 | Q9NQ66 | |
| TVSVQQLFSTLPVRH | 156 | P54278 | |
| PAVSLNRNVQVTLHT | 681 | Q9C026 | |
| IQDSHVSISPSRNVG | 681 | Q17R98 | |
| TGQVNLQRSETEPHL | 176 | O14668 | |
| ESGAVIHPATQTSLQ | 401 | Q9NS68 | |
| VRSVGNTLVLHQTAL | 236 | Q86WT1 | |
| LQQVLTGLRAVTHTS | 791 | Q9BTW9 | |
| ATAHSPTGIIIQNTD | 346 | Q9WJR5 | |
| IPQQGIIRSLNVHVS | 1586 | Q13395 | |
| HVTLEPGANQITFRT | 731 | P48553 | |
| TNGIDNHVPTSTLVQ | 186 | Q9H0M0 | |
| LQVSLFTPANAVIGH | 101 | Q96PF1 | |
| GNVISVIQHTNSLSR | 796 | P31629 | |
| HLPALQSVSVGQDVR | 301 | Q8WUA8 | |
| VVDLLSNRNNHTGPS | 281 | Q5T5U3 | |
| NISSVGRFLSPVQHL | 286 | Q8N8C0 | |
| TGISVIQHTNSLSRP | 1131 | P15822 | |
| SQPLVVSSHDRAGQQ | 406 | Q06418 | |
| IHNRPSLASQTNVGS | 516 | Q70EL1 | |
| NHTITLPQNSITLNG | 536 | Q5VV43 | |
| IVQLPHLSNSTSRTA | 376 | Q9ULH4 | |
| PQGSLTIQHATQRDA | 2791 | Q9NR99 | |
| SSDNSVIRQLVNHPL | 861 | Q8NEV4 |